Company intelligence / Profile preview

Softhaler

Berlin, Berlin, Germany

Ownership: Private
Development stage: Other

Overview

Softhaler was a German medical technology company focused on the development of advanced inhalation systems for respiratory drug delivery. The company's primary asset was the Softhaler dry powder inhaler (DPI), a multi-dose device designed to deliver precise amounts of medication to the lungs with high efficiency. In 2001, the company was acquired by Vectura Group, which integrated the Softhaler technology into its broader respiratory platform. This technology served as the foundation for subsequent device iterations, including the GyroHaler, used in various asthma and COPD treatments.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Aventis

Beyond the preview

Go deeper on Softhaler.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Softhaler.

Explore the full profile